Signal Detection of Potential Hepatotoxic Drugs: Case-Control Study Using Both a Spontaneous Reporting System and Electronic Medical Records
Author:
Affiliation:
1. Division of Pharmacology, Department of Biomedical Sciences, Nihon University School of Medicine
2. Division of Genomic Epidemiology and Clinical Trials, Clinical Trials Research Center, Nihon University School of Medicine
Publisher
Pharmaceutical Society of Japan
Subject
Pharmaceutical Science,Pharmacology,General Medicine
Link
https://www.jstage.jst.go.jp/article/bpb/44/10/44_b21-00407/_pdf
Reference57 articles.
1. 1) Senior JR. Drug hepatotoxicity from a regulatory perspective. Clin. Liver Dis., 11, 507–524, vi (2007).
2. 2) Lee WM. Drug-induced acute liver failure. Clin. Liver Dis., 17, 575–586, viii (2013).
3. 3) Suk KT, Kim DJ. Drug-induced liver injury: present and future. Clin. Mol. Hepatol., 18, 249–257 (2012).
4. 4) Meier Y, Cavallaro M, Roos M, Pauli-Magnus C, Folkers G, Meier PJ, Fattinger K. Incidence of drug-induced liver injury in medical inpatients. Eur. J. Clin. Pharmacol., 61, 135–143 (2005).
5. 5) Aiso M, Takikawa H, Tsuji K, et al. Analysis of 307 cases with drug-induced liver injury between 2010 and 2018 in Japan. Hepatol. Res., 49, 105–110 (2019).
Cited by 10 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. An investigation of broad-spectrum antibiotic-induced liver injury based on the FDA Adverse Event Reporting System and retrospective observational study;Scientific Reports;2024-08-06
2. Decreased Hepatic Functional Reserve Increases the Risk of Piperacillin/Tazobactam-Induced Abnormal Liver Enzyme Levels: A Retrospective Case-Control Study;Annals of Pharmacotherapy;2024-06-05
3. Pharmacovigilance Strategies to Address Resistance to Antibiotics and Inappropriate Use—A Narrative Review;Antibiotics;2024-05-16
4. Effect of Ceftriaxone Dosage and Albumin–Bilirubin Score on the Risk of Ceftriaxone-Induced Liver Injury;Biological and Pharmaceutical Bulletin;2023-12-01
5. Investigation of tazobactam/piperacillin– or meropenem–induced liver injury based on retrospective observational study and the FDA Adverse Event Reporting System;2023-11-17
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3